CDX Holdings appoints new non-executive vice-chairman
This article was originally published in Scrip
CDX Holdings, the parent company of Caris Diagnostics (Caris Dx) and Caris Molecular Diagnostics (CMDx), has appointed Dr George Poste non-executive vice-chairman and chief scientific advisor, and has also made him non-executive chairman of CMDx. Dr Poste has previously led research programmes in biotechnology, nanotechnology, materials science and advanced computing at Arizona State University and has served as chairman of the task force on bioterrorism for the US Department of Defense, where he also serves as a member of the Defense Science Board. He is also a member of the Institute of MedicineBoard of Global Health.